Articles dans des revues avec comité de lecture (405)
  1. 152. Peakman, M., Eizirik, D. L., Eisenbarth, G., & Pociot, F. (2012). Type 1 diabetes (poster). Nature reviews. Endocrinology., epub 21.09.2012 http://www.nature.com/nrendo/posters/type1diabetesmellitus/.
  2. 153. Santin Gomez, I., Moore, F., Grieco, F. A., Marchetti, P., Brancolini, C., & Eizirik, D. L. (2012). USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Database : the journal of biological databases and curation, 3, e419. doi:10.1038/cddis.2012.158
  3. 154. Kolb, H., & Eizirik, D. L. (2012). Resistance to type 2 diabetes mellitus: a matter of hormesis? Nature reviews. Endocrinology, 8(3), 183-192. doi:10.1038/nrendo.2011.158
  4. 155. Eizirik, D. L., & Grieco, F. A. (2012). On the immense variety and complexity of circumstances conditioning pancreatic beta-cell apoptosis in type 1 diabetes. Diabetes (New York, N.Y.), 61(7), 1661-1663. doi:10.2337/db12-0397
  5. 156. Korf, H., Wenes, M., Stijlemans, B., Takiishi, T., Robert, S., Miani, M., Eizirik, D. L., Gysemans, C., & Mathieu, C. (2012). 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology, 217(12), 1292-1300. doi:10.1016/j.imbio.2012.07.018
  6. 157. Andralojc, K., Srinivas, M., Brom, M., Joosten, L., de Vries, I. J. M., Eizirik, D. L., Boerman, O. C., Meda, P., & Gotthardt, M. (2012). Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia, 55(5), 1247-1257. doi:10.1007/s00125-012-2491-7
  7. 158. Colli, M. L., Nogueira, T. C., Allagnat, F., Andrade Da Cunha, D., Gurzov, E. N., Cardozo, A. K., Roivainen, M., Op De Beeck, A., & Eizirik, D. L. (2011). Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance. P L o S Pathogens, 7(9), 1002267. doi:10.1371/journal.ppat.1002267
  8. 159. Gurzov, E. N., & Eizirik, D. L. (2011). Bcl-2 proteins in diabetes: mitochondrial pathways of beta-cell death and dysfunction. Trends in cell biology, 21(7), 424-431. doi:10.1016/j.tcb.2011.03.001
  9. 160. Barthson, J., Germano, C. M. R. C., Moore, F., Maida, A., Drucker, D. J., Marchetti, P., Gysemans, C., Mathieu, C., Nuñez, G., Jurisicova, A., Eizirik, D. L., & Gurzov, E. N. (2011). Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation. The Journal of biological chemistry, 286(45), 39632-39643. doi:10.1074/jbc.M111.253591
  10. 161. Arif, S., Moore, F., Marks, K., Bouckenooghe, T., Dayan, C. M., Planas, R., Vives-Pi, M., Powrie, J., Tree, T., Marchetti, P., Huang, G. C., Gurzov, E. N., Pujol-Borrell, R., Eizirik, D. L., & Peakman, M. (2011). Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes (New York, N.Y.), 60(8), 2112-2119. doi:10.2337/db10-1643
  11. 162. Santin Gomez, I., Moore, F., Colli, M. L., Gurzov, E. N., Marselli, L., Marchetti, P., & Eizirik, D. L. (2011). PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic bata-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes (New York, N.Y.), 60(12), 3279-3288. doi:10.2337/db11-0758
  12. 163. Allagnat, F., Andrade Da Cunha, D., Moore, F., Vanderwinden, J. M., Eizirik, D. L., & Cardozo, A. K. (2011). Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to beta-cell apoptosis. Cell death and differentiation, 18(2), 328-337. doi:10.1038/cdd.2010.105
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 40 41 Suivant >>